Spectazole

Tinea Pedis, Inflammation, Fungal eye infections + 17 more

Treatment

20 Active Studies for Spectazole

What is Spectazole

Econazole

The Generic name of this drug

Treatment Summary

A broad-spectrum antifungal medication with some effectiveness against certain types of bacteria. This drug can be used on the skin, orally, or injected to treat fungal infections.

Spectazole

is the brand name

image of different drug pills on a surface

Spectazole Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Spectazole

Econazole

1982

30

Effectiveness

How Spectazole Affects Patients

Econazole is an antifungal medication used to treat fungal infections. It works by stopping fungi from producing substances that are necessary for them to survive. This medication will not work on infections caused by bacteria or viruses.

How Spectazole works in the body

Econazole works by blocking the enzyme that is needed to make a key component of fungal cell membranes. Without this component, the cell membrane becomes more permeable and its contents leak out. Econazole can also interfere with fungal respiration, membrane phospholipids, yeast transformation, purine uptake, and triglyceride or phospholipid biosynthesis.

When to interrupt dosage

The measure of Spectazole is contingent upon the diagnosed condition, including Cellulitis, Tinea cruris and Fungal eye infections. The dosage fluctuates, in accordance with the technique of delivery (e.g. Cream - Topical or Topical) detailed in the table beneath.

Condition

Dosage

Administration

Ringworm

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Fungal eye infections

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Atopic Dermatitis

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Intertrigo

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Skin

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Balanitis candida

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

cutaneous candidiasis

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Tinea Pedis

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Tinea Pedis

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

severe local inflammatory reactions

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Eczema

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Tinea Versicolor

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Inflammation

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

cutaneous dermatophyte infection

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Skin candida

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Cellulitis

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Shingles

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Tinea Cruris

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Tinea

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Mycoses

, 0.01 mg/mg, 10.0 mg, 150.0 mg, 1.0 %, 10.0 mg/mL

, Topical, Cream, Cream - Topical, Suppository, Suppository - Vaginal, Vaginal, Aerosol, foam - Topical, Aerosol, foam, Cream - Vaginal, Solution, Solution - Topical, Kit - Topical, Kit

Warnings

There are 20 known major drug interactions with Spectazole.

Common Spectazole Drug Interactions

Drug Name

Risk Level

Description

Alfuzosin

Major

The metabolism of Alfuzosin can be decreased when combined with Econazole.

Avanafil

Major

The metabolism of Avanafil can be decreased when combined with Econazole.

Bromocriptine

Major

The serum concentration of Bromocriptine can be increased when it is combined with Econazole.

Cabergoline

Major

The serum concentration of Cabergoline can be increased when it is combined with Econazole.

Cariprazine

Major

The metabolism of Cariprazine can be decreased when combined with Econazole.

Spectazole Toxicity & Overdose Risk

To date, no cases of econazole overdose in humans have been reported. In animal studies, a toxic dose of econazole was found to be 462mg/kg in mice, 668mg/kg in rats, 272mg/kg in guinea pigs, and over 160mg/kg in dogs.

Spectazole Novel Uses: Which Conditions Have a Clinical Trial Featuring Spectazole?

303 active studies are currently being conducted to determine the efficacy of Spectazole in treating Atopic Dermatitis, Eczema and Cellulitis.

Condition

Clinical Trials

Trial Phases

Cellulitis

0 Actively Recruiting

Tinea Versicolor

0 Actively Recruiting

Tinea

0 Actively Recruiting

Inflammation

61 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 3, Phase 1

Skin candida

0 Actively Recruiting

Fungal eye infections

0 Actively Recruiting

Tinea Pedis

0 Actively Recruiting

Intertrigo

0 Actively Recruiting

Atopic Dermatitis

17 Actively Recruiting

Phase 2, Phase 3, Not Applicable, Phase 4, Phase 1

Eczema

0 Actively Recruiting

Ringworm

0 Actively Recruiting

Balanitis candida

0 Actively Recruiting

Tinea Pedis

0 Actively Recruiting

cutaneous candidiasis

0 Actively Recruiting

Skin

0 Actively Recruiting

Mycoses

0 Actively Recruiting

Tinea Cruris

0 Actively Recruiting

severe local inflammatory reactions

0 Actively Recruiting

Shingles

2 Actively Recruiting

Phase 2, Phase 1

cutaneous dermatophyte infection

0 Actively Recruiting

Spectazole Reviews: What are patients saying about Spectazole?

5

Patient Review

10/18/2008

Spectazole for Skin Infection due to a Candida Yeast

Lotrisone has been a miracle drug for me. I've used it for about 10 years to combat rashes in my groin area caused by sweat, and it's always worked within two days.

5

Patient Review

12/1/2008

Spectazole for Ringworm of the Body

We tried over-the-counter treatments for three weeks, but it only seemed to make the symptoms worse. Then the doctor prescribed Spectazole. It was a miracle! Within a week you couldn't even see it, but we continued the treatment as directed. THANK YOU!

5

Patient Review

9/18/2008

Spectazole for Inflammation and Infection of Nail Cuticle

I was using Penlac for three years with little to show for it. This new medication corrected the problem in just three months.

3

Patient Review

8/7/2009

Spectazole for Ringworm of the Body

While this treatment is easy to use and did clear up my ringworm, I found the side effects incredibly severe. My skin was constantly itchy, burning, red, and peeling.

2.3

Patient Review

7/3/2013

Spectazole for Athlete's Foot

Unfortunately, this treatment caused me to break out in pimples, blisters, and red spots just three days after I started using it. It was terrible, and I'm 73 years old.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about spectazole

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does it take for econazole cream to work?

"It usually takes around a week or two for people to start seeing improvement in their symptoms after using econazole cream. However, it's important to use the cream for the recommended amount of time indicated on the packaging (which is usually 2 weeks for most conditions, and 1 month for athlete's foot), even if your symptoms have mostly gone away."

Answered by AI

What is nitrate cream used for?

"This medicine works by killing the fungi that cause these infections.

Econazole nitrate cream is a cream used to treat fungal infections of the skin. It works by killing the fungi that cause infection."

Answered by AI

What's econazole used for?

"Econazole foam is a prescription medication used to treat ringworm of the foot (interdigital tinea pedis; athlete's foot). It is available as a cream."

Answered by AI

What is Spectazole cream used for?

"Econazole is used to treat fungal infections of the skin such as athlete's foot, jock itch, and ringworm. This medication is also used to treat pityriasis (tinea versicolor), a fungal infection that causes lightening or darkening of the skin on the neck, chest, arms, or legs."

Answered by AI

Clinical Trials for Spectazole

Image of Texas Tech University Health Sciences Center/ University Medical Center Lubbock in Lubbock, United States.

PSP Monitoring for Sepsis in Burns

18 - 89
All Sexes
Lubbock, TX

The goal of this clinical trial is to learn if using pancreatic stone protein (PSP) test results helps doctors find and treat sepsis earlier in adults with serious burn injuries. The study will also look at whether using PSP is safe and practical in the burn intensive care unit. The main questions it aims to answer are: * Does seeing PSP test results help doctors start the right antibiotics sooner? * Does using PSP reduce unnecessary antibiotic use? * Does using PSP improve recovery and other health outcomes? Researchers will compare two groups of patients. One group will receive standard care, and their PSP test results will be hidden from their care team. The other group will receive standard care, but their care team will be able to see the PSP test results and use them to help make treatment decisions. Participants will: * Be randomly assigned to one of the two study groups. * Have a small blood sample taken within 24 hours after being admitted to the burn ICU and then once each weekday while they are in the ICU. * Receive the usual care for burn injuries and sepsis throughout the study.

Waitlist Available
Has No Placebo

Texas Tech University Health Sciences Center/ University Medical Center Lubbock

Brian Schneider, MD

Abionic SA

Image of Nicholas Institute of Sports Medicine & Athletic Trauma (NISMAT) in New York, United States.

Fruit Juice for Inflammation

18 - 65
All Sexes
New York, NY

Dietary patterns and physical inactivity common in Western societies have been associated with chronic low-grade inflammation and an increased risk of non-communicable health conditions. Fruits and vegetables contain polyphenols and other bioactive compounds that may have antioxidant and anti-inflammatory properties and may influence inflammatory biomarkers. This study will evaluate the effects of increased consumption of a fruit juice on inflammatory biomarkers and exercise capacity in adults with mildly elevated inflammation. Approximately 40 participants will be randomly assigned to consume one of two fruit juice interventions daily for approximately 2 weeks. Changes in C-reactive protein (CRP) and exercise capacity, assessed using a 6-minute walk test, will be evaluated before and after the intervention and compared between the two groups.

Recruiting
Has No Placebo

Nicholas Institute of Sports Medicine & Athletic Trauma (NISMAT)

Christopher Tanayan, MD

Have you considered Spectazole clinical trials?

We made a collection of clinical trials featuring Spectazole, we think they might fit your search criteria.
Go to Trials
Image of University of Utah in Salt Lake City, United States.

Metformin for Muscle Weakness

18+
All Sexes
Salt Lake City, UT

The purpose of this research study is to determine if Metformin taken after anterior cruciate ligament reconstruction (ACLR) surgery can decrease muscle fibrosis, cellular senescence and improve leg strength. ACL injury and surgery increase muscle collagen content and inflammation which slows the recovery of muscle and function and ultimately impacts the quality of life. Individuals enrolled in the study will be randomized to receive metformin (or placebo) for 4 months after surgery. The investigators will measure muscle strength and inflammatory markers in muscle biopsy samples after the intervention period. Investigators will also follow up with participants 8 months later to determine the lasting effects of the intervention.

Phase < 1
Waitlist Available

University of Utah

Micah Drummond

Image of Reichwald Health Sciences Centre in Kelowna, Canada.

Broccoli Sprout Extract + Exercise for Inflammation

19 - 35
All Sexes
Kelowna, Canada

The study consist of 3 interventional periods which will be completed by each consenting participant in a randomized, crossover fashion. The interventional periods will be separated by a minimum 1 week washout period. One of the interventions consists of 4 days of daily supplementation with the commercially available broccoli sprout extract capsules (BrocElite). Another intervention will consist of 4 days of daily supervised treadmill running. The exercise protocol consists of 4 minutes of high-intensity running running followed by a 3 minute recovery period, repeated for a total of 4 repetitions. The last intervention combines the above two and consists of 4 days of daily supplementation and daily supervised exercise training. Before and after each intervention, basic anthropometrics (weight, heart rate, and blood pressure) will be recorded, and a venous blood sample will be collected. Blood samples will be analyzed for metabolic and inflammatory markers. Participants will be asked to refrain from structured exercise, alcohol consumption, and broccoli consumption during each of the experimental periods. Before any testing, willing participants will provide informed consent, and fill out a few demographic, and lifestyle questionnaires. The study will be conducted at the University of British Columbia in Kelowna, BC, Canada.

Recruiting
Has No Placebo

Reichwald Health Sciences Centre

Have you considered Spectazole clinical trials?

We made a collection of clinical trials featuring Spectazole, we think they might fit your search criteria.
Go to Trials
Image of University of Oklahoma Health Campus in Oklahoma City, United States.

Disulfiram for Rheumatoid Arthritis

18 - 75
All Sexes
Oklahoma City, OK

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and systemic immune activation. Obesity is common among individuals with RA and is associated with increased disease activity, reduced treatment response, and worse functional outcomes. Inflammation in adipose tissue, driven in part by activation of the NLRP3 inflammasome and downstream gasdermin D (GSDMD)-mediated pathways, may contribute to systemic inflammation and RA disease severity. Disulfiram (DSF), an FDA-approved medication for alcohol use disorder, has recently been identified as an inhibitor of GSDMD-mediated inflammatory signaling and pyroptosis. Preclinical studies suggest that DSF reduces inflammasome activation, inflammatory cytokine release, and metabolic dysfunction. This study is a 12-week, randomized, double-blind, placebo-controlled pilot trial designed to evaluate the safety, tolerability, and preliminary efficacy of DSF in overweight and obese adults with active RA despite stable disease-modifying antirheumatic drug (DMARD) therapy. Participants will be randomized to receive either DSF (250 mg daily) or placebo. The primary objective is to assess safety and tolerability. Secondary and exploratory objectives include evaluating the effects of DSF on systemic inflammation, RA disease activity, metabolic parameters, and adipose tissue inflammasome activation. Findings from this study will inform the feasibility and design of larger clinical trials targeting GSDMD-mediated inflammation in RA.

Phase 2
Waitlist Available

University of Oklahoma Health Campus

Beatriz Y Hanaoka, MD, MSc

Have you considered Spectazole clinical trials?

We made a collection of clinical trials featuring Spectazole, we think they might fit your search criteria.
Go to Trials